Control Group:Sorafenib

3 trials

Sponsors

Beijing You-An Hospital, Capital Medical University, Longhua Hospital, Shanghai University of Traditional Chinese Medicine

Conditions

Hepatocellular CarcinomaHepatocellular carcinoma

Early Phase 1

Study for Clinical application of iNKT cell immunotherapy for advanced HCC

Active, not recruitingChiCTR1900027832

Beijing You-An Hospital, Capital Medical UniversityHepatocellular carcinoma

Start: 2019-11-29Updated: 2019-12-10

Phase 4

Prevention and Treatment of Recurrence and Metastasis of Hepatocellular Carcinoma after Operation with Ganyanshu Decoctions

RecruitingChiCTR2000035749

Longhua Hospital, Shanghai University of Traditional Chinese MedicineHepatocellular Carcinoma

Start: 2020-10-02Updated: 2020-08-17

Prevention and Treatment of Recurrence and Metastasis of Hepatocellular Carcinoma after Operation with Ganyanshu Decoctions

RecruitingITMCTR2000003577

Longhua Hospital, Shanghai University of Traditional Chinese MedicineHepatocellular Carcinoma

Start: 2020-10-02Updated: 2023-02-20